NunaBio, a next-gen DNA manufacturing company, has secured £6.5 million in funding to scale-up its DNA platform and accelerate its continued growth as a commercially focused infrastructure business for synthetic biology, therapeutics, and research.
Ampersand Capital Partners, a private equity firm with deep operational expertise scaling life sciences and healthcare companies, announced it has completed the sale of Tjoapack to Alcami Corporation.
Vetter, a Contract Development and Manufacturing Organisation (CDMO), is celebrating the start of construction on its new site in Saarlouis with a traditional groundbreaking ceremony.
Exciva, a biopharmaceutical company developing novel therapeutic compounds for the treatment of neuropsychiatric conditions, has announced the appointment of Mark Altmeyer as chairman of its board of directors.
Asahi Kasei, a diversified global company, announced the successful completion of its acquisition of Aicuris Anti-infective Cures (Aicuris), a German-based biopharmaceutical company.
Justin Wilson, partner and life sciences sector specialist at Withers & Rogers, highlights the importance of ensuring IP readiness ahead of an expected surge in M&A activity as the industry approaches the patent cliff.
Daikin Rental Solutions has announced an expansion of its fleet, combining new high-capacity cooling systems, low-carbon heating solutions, process cooling equipment, and UK-manufactured air handling units to meet growing demand for HVAC.
Vetter, a global Contract Development and Manufacturing Organisation (CDMO), announced progress in the continued expansion of its global clinical manufacturing network.
Er-Kim has announced that it has signed an exclusive agreement with LEO Pharma A/S to commercialise LOQTORZI (toripalimab) in select regions in Central and Eastern Europe (CEE).
